Cargando…
Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors
Evasion of innate immunity represents a frequently employed method by which tumor cells survive and thrive. Previously, the development of immunotherapeutic agents capable of overcoming this evasion has realized pronounced clinical utility across a variety of cancer types. More recently, immunologic...
Autores principales: | Vellani, Shahnaz D., Nigro, Anthony, Varatharajan, Shangari, Dworkin, Lance D., Creeden, Justin Fortune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10004351/ https://www.ncbi.nlm.nih.gov/pubmed/36903295 http://dx.doi.org/10.3390/molecules28052047 |
Ejemplares similares
-
The application, safety, and future of ex vivo immune cell therapies and prognosis in different malignancies
por: Einloth, Katelyn R., et al.
Publicado: (2023) -
Antioxidant and Anti-Tumor Effects of Dietary Vitamins A, C, and E
por: Didier, Alexander J., et al.
Publicado: (2023) -
Homologous recombination proficiency in ovarian and breast cancer patients
por: Creeden, Justin Fortune, et al.
Publicado: (2021) -
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Mihályová, Jana, et al.
Publicado: (2021) -
Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)